Bioequivalence evaluation of two sertraline tablet formulations in healthy male volunteers after a single dose administration

International Journal of Clinical Pharmacology and Therapeutics

Volumn 37, Issue 3, 1999, Pages 120-124

  Zhu, C J ^a   Wu, J F ^a   Qu, Z W ^a   Chen, L M ^b   Zhang, J T ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b Ruili Analytical Equipment Company   (China)

Author keywords

Bioequivalence; Human; Pharmacokinetics; Sertraline; Single dose

Indexed keywords

SERTRALINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG HALF LIFE; ELECTRON CAPTURE DETECTION; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NAUSEA; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; TABLET FORMULATION; TREMOR; VERTIGO;

ADULT; AREA UNDER CURVE; CHEMISTRY, PHARMACEUTICAL; CHINA; CROSS-OVER STUDIES; ENGLAND; HALF-LIFE; HUMANS; MALE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TABLETS; THERAPEUTIC EQUIVALENCY;

EID: 0033065335     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Chouinard G, Goodman W, Jenike M, Resmussen S, White K, Hackett E, Gaffney M, Bick PA 1990 Results of a double-blind placebo-controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Psychopharmacol Bull 26: 279-284
2. Doogan DP, Caillard V 1988 Sertraline: a new antidepressant. J Clin Psychiatr 49 (Suppl 8): 46-51
3. Doogan DP, Caillard V 1992 Sertraline in the prevention of depression. Br J Psychiatry 160: 217-222
4. Endrenyi L, Tothfalusi L 1997 Truncated AUC evaluates effectively the bioequivalence of drugs with long half-lives. Int J Clin Pharmacol Ther 35: 142-150
5. Hauschke D, Steinijans VW, Diletti E 1990 A distribution-free procedure for the statistical analysis of bioequivalence studies. Int J Clin Pharmacol Ther Toxicol 28: 72-78
6. Koe BK, Weissman A, Welch WM, Brown RG 1983 Sertraline: a new selective inhibitor of serotonin uptake. Psychopharmacol Bull 19: 687-691
7. Mendels J 1987 Clinical experience with serotonin reuptake inhibiting antidepressants. J Clin Psychiatry 48 (Suppl): 26-30
8. Murdoch D, McTavish D 1992 Sertraline: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depression and obsessive-compulsive disorder. Drugs 44: 604-624
9. Niazi SK 1997 Partial-area method in bioequivalence assessment: naproxen. Biopharm Drug Dispos 18: 103-116
10. Ronfeld RA, Tremaine LM, Wilner KD 1997a Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers. Clin Pharmacokinet 32 (Suppl 1): 22-30
11. Ronfeld RA, Wilner KD, Baris BA 1997b Sertraline: Chronopharmacokinetics and the effect of coadministration with food. Clin Pharmacokinet 32 (Suppl 1): 50-55
12. Schuirmann DJ 1987 A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm 15: 657-680
13. Steinijans VW, Hauschke D 1990 Update on the statistical analysis of bioequivalence studies. Int J Clin Pharmacol Ther Toxicol 28: 105-110
14. Tremaine LM, Wwlch WM, Ronfeld RA 1989 Metabolism and disposition of the 5-hydroxytryptamine uptake blocker sertraline in the rat and dog. Drug Metab Dispos 17: 542-550
15. Tremaine LM, Joerg EA 1989 Automated gas chromatographic-electron-capture assay for the selective serotonin uptake blocker sertraline. J Chromatogr 496: 423-429
16. 0-72 in bioequivalence assessment for drugs with a long half-life. Pharm Res 13: s-477